la l carnitina es mala Carnitina: tipos y metabolismo energético La L-carnitina te da mal

doi: 10.1055/s-0030-1250604

This size-dependent behavior must be considered when interpreting experimental results, as nano-scale particles may overrepresent bioavailability and toxicity compared to typical human exposures that involve larger, less mobile microplastics

Prevalence and Clinical Implications of PPM1D Truncating Mutations in Therapy-Related Myeloid Neoplasms

In such patients, treatment with biologic therapies (monoclonal antibodies) that specifically target type 2 cytokines may be an effective in both reducing asthma symptoms, as well as reducing patient exposure to systemic corticosteroids, and their unwanted adverse effects